期刊文献+

阿芬太尼对糖尿病大鼠心肌缺血再灌注损伤及VEGFA/Ang-1通路的影响 被引量:7

Effects of Alfentanil on Myocardial Ischemia-reperfusion Injury and VEGFA/Ang-1 Pathway in Diabetic Rats
下载PDF
导出
摘要 目的:探讨阿芬太尼对糖尿病大鼠心肌缺血/再灌注(I/R)损伤及血管内皮生长因子A(VEGFA)/血管紧张素-1(Ang^(-1))通路的影响。方法:用链脲佐菌素(60 mg·kg^(-1))腹腔注射的方法制备大鼠糖尿病模型,造模成功后制备I/R模型。将造模成功的Wistar大鼠随机分为假手术组、I/R组、吗啡组(0.1 mg·kg^(-1))和阿芬太尼低、高剂量组(3,6 mg·kg^(-1)),每组10只。在结扎前30 min,阿芬太尼低、高剂量组和吗啡组尾静脉注射相应剂量药物,假手术组和I/R组尾静脉注射等量生理盐水。再灌注2 h,对大鼠进行心功能检测,处死大鼠,检测血清中肌酸激酶同工酶(CK-MB)、乳酸脱氢酶(LDH)、丙二醛(MDA)和超氧化物歧化酶(SOD)水平;检测心肌组织中VEGFA、Ang^(-1)和半胱氨酸天冬氨酸蛋白酶-3(caspase-3)蛋白水平。结果:与假手术组比较,其余各组大鼠左心室舒张压(LVDP)、血清中SOD、心肌组织中VEGFA和Ang^(-1)蛋白水平降低,左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)、血清中CK-MB、LDH、MDA和心肌组织中caspase-3水平升高(P<0.05)。与I/R组比较,阿芬太尼低、高剂量组和吗啡组大鼠LVDP、血清中SOD、心肌组织中VEGFA和Ang^(-1)蛋白水平升高,LVEDD、LVESD、血清中CK-MB、LDH、MDA和心肌组织中caspase-3水平降低(P<0.05)。阿芬太尼低剂量组与高剂量组、吗啡组比较,以上各指标差异有统计学意义(P<0.05);阿芬太尼高剂量组和吗啡组作用相似,差异无统计学意义(P>0.05)。结论:阿芬太尼可以激活VEGFA/Ang^(-1)通路,降低caspase-3水平,对糖尿病大鼠心肌I/R损伤发挥保护作用。 Objective:To investigate the effects of alfentanil on myocardial ischemia/reperfusion(I/R)injury and vascular endothelial growth factor A(VEGFA)/angiotensin-1(Ang^(-1))pathway in diabetic rats.Methods:The rat diabetes model was made by intraperitoneal injection of streptozotocin(60 mg·kg^(-1)),and the I/R model was prepared after successful modeling.Wistar rats were randomly divided into sham operation group,I/R group,morphine group(0.1 mg·kg^(-1)),alfentanil low and high dose groups(3 and6 mg·kg^(-1))with 10 rats in each group.At 30 minutes before ligation,morphine group,alfentanil low and high dose groups were injected with corresponding dose of drug,and the sham operation group and I/R group were injected with the same amount of normal saline via tail vein.After 2 hours of reperfusion,the rats were tested for cardiac function,and then the rats were sacrificed.The serum levels of creatine kinase isoenzymes(CK-MB),lactic dehydrogenase(LDH),malondialdehyde(MDA)and superoxide dismutase(SOD)were detected,and the levels of VEGFA,Ang^(-1)and cysteinyl aspartate specific proteinase-3(caspase-3)protein in myocardial tissue were also detected.Results:Compared with those in the sham operation group,the levels of left ventricular diastolic pressure(LVDP),serum SOD,myocardial tissue VEGFA and Ang^(-1)in the other groups were decreased,and the levels of left ventricular end diastolic diameter(LVEDD),left ventricular endsystolic diameter(LVESD),serum CK-MB,LDH and MDA,and myocardial tissue caspase-3 were increased(P<0.05).Compared with those in I/R group,the levels of LVDP,serum SOD,myocardial tissue VEGFA and Ang^(-1)in the low dose alfentanil group,high dose alfentanil group and morphine group were increased,and the levels of LVEDD,LVESD,serum CK-MB,LDH and MDA,and myocardial tissue caspase-3 were decreased(P<0.05).Compared with those in alfentanil high dose group and morphine group,the above indicators had statistically significant differences in alfentanil low dose group(P<0.05);alfentanil high dose group and morphine group had similar effects,and there were no statistically significant differences(P>0.05).Conclusion:Alfentanil can reduce the level of Caspase-3 by activating VEGFA/Ang^(-1)pathway,which plays a protective effect on myocardial I/R injury in diabetic rats.
作者 王静 杨路宗 燕枫 Wang Jing;Yang Luzong;Yan Feng(Department of Anesthesiology,Tianshan Hospital of Traditional Chinese Medicine of Changning District in Shanghai City,Shanghai 200000,China;Department of Anesthesiology,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine;Department of Anesthesiology,Jiuting Hospital of Songjiang District in Shanghai City)
出处 《中国药师》 CAS 2021年第5期845-849,共5页 China Pharmacist
基金 上海市科学技术委员会科研计划项目(编号:19401901003)。
关键词 阿芬太尼 糖尿病 心肌缺血/再灌注损伤 血管内皮生长因子A/血管紧张素-1通路 Alfentanil Diabetes Myocardial ischemia/reperfusion injury VEGFA/Ang-1 pathway
  • 相关文献

参考文献5

二级参考文献15

  • 1Loren E WOLD,Asli F CEYLAN-ISIK,Jun REN.Oxidative stress and stress signaling: menace of diabetic cardiomyopathy[J].Acta Pharmacologica Sinica,2005,26(8):908-917. 被引量:23
  • 2Chen H, Higashino H, Kamenov ZA, et al. Preserved postischemic heart function in sucrose-fed type 2 diabetic OLETF rats [ J ]. Life Sci, 2003, 72(25): 2839-2851.
  • 3Scarabelli TM, Knight R, Stephanou A, et al. Clinical implications of apoptosis in ischemic myocardium[J]. Curr Probl Cadiol, 2006, 31 (3) : 151-264.
  • 4Jin YC, Kim W, Ha YM, et al. Propofol limits rat myocardial ischemia and reperfusion injury with an associated reduction inapoptotic cell death in vivo [ J ]. Vascular Pharmacology, 2009, 50 (1-2) : 71-77.
  • 5Zhang M, Lv XY, Li J, et al. The characterization of high-fat diet and multiple low-dose streptozotoein induced type 2 diabetes rat model [J]. Exp Diabetes Res, 2008,2008 : 704045.
  • 6Rohrbaeh S, Muller-Werdan U, Werdan K, et al. Apoptosis-mod- ulating interaction of the neuregulin/erbB pathway with anthraeyelines in regulating Bcl-xS and Bcl-xL in cardiomyocytes[J]. J Mol Cell Cardiol, 2005, 38 (3):485-493.
  • 7Javadov SA, Lim KH, Kerr PM, et al. Protection of hearts from reperfusion injury by propofol is assoated with inhibition of the mitochondrial permeability transition [ J ]. Cadiovase Res, 2000, 45 (2) : 360-369.
  • 8王红杰,张建新,李兰芳,武宏敏.异丙酚预先给药对糖尿病大鼠心肌缺血再灌注损伤的影响[J].中华麻醉学杂志,2008,28(10):939-943. 被引量:6
  • 9张宏考,方明,肖俊会,黄永章,杨建业.黄连素预处理对大鼠心肌缺血再灌注损伤的保护作用[J].郧阳医学院学报,2009,28(1):20-22. 被引量:5
  • 10张伟.人类caspase家族蛋白酶与凋亡[J].国外医学(遗传学分册),1999,22(6):290-293. 被引量:35

共引文献11

同被引文献93

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部